ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0706

Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study

Roberto D'Alessandro1, Francois Zimmermann2, sandrine jousse3, AURORE BLEUZEN4, Guillaume Coiffier5, Jérôme Avouac6, Alain Lescoat7 and Yannick Allanore8, 1Rheumatology Unit, Cochin Hospital, Paris, France, Paris, France, 2Internal medicine department, University Hospital of Rennes, Rennes, France, Rennes, France, 3LBAI, UMR1227, University of Brest, CHU Brest, Brest, France, Brest, France, 4Medical Imaging, University Hospital of Tours, Tours, France, Tours, France, 5Dinan Hospital, Dinan, France, 6Hôpital Cochin, AP-HP Centre - Université Paris Cité, Paris, France, 7CHU Rennes University Hospital, Rennes, France, 8Department of Rheumatology, Université Paris Cité UFR de Médecine, Paris, France

Meeting: ACR Convergence 2025

Keywords: Systemic sclerosis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Ultrasound (US) abnormalities of major salivary glands are frequent in systemic sclerosis (SSc) patients. However, US role is not yet fully understood, and the data available on this topic is limited.The aim of this study is to evaluate the role of major salivary gland ultrasound (SGUS) in patients with SSc

Methods: We consecutively recruited patients with SSc who were regularly followed in two Rheumatology and Internal Medicine centers in France between 2023 and 2024.- SGUS was performed with a 4–15 MHz and 4–12.5 MHz linear ultrasound probe, by two operators.- The parotid and submandibular glands were bilaterally studied and scored on a 0 to 4 scale using the Jousse-Joulin (JJ) score, based on progressive bands and hypoechoic areas.- SGUS findings were considered pathological with a JJ score ≥ 2 in at least one gland.- Hyperechoic bands indicating fibrosis were evaluated with a 0 to 3 scoring system based on the JJ reference atlas.- A fibrosis score ≥ 2 in at least one gland was considered pathological. US data was compared to clinical and biochemical data of our patients.

Results: A total of 123 patients were included: 13 men (10.6%) and 110 women (89.4%), with a mean age of 58.5 ± 13.2 years. Thirty-three (26.8%) had diffuse cutaneous SSc. Subjective sicca syndrome was present in 88 patients (71.5%), with objective sicca syndrome in 77% of cases. An overlap with Sjögren’s syndrome was diagnosed in 29 patients (23.6%), all of whom had pathological minor salivary gland biopsies (MSGB). Fifty-six patients (45.5%) had a JJ score ≥ 2, while 45 (36.6%) had a fibrosis score ≥ 2.- The group of patients presenting with a JJ score ≥ 2, compared to the group JJ < 2, presented significatively more frequently an overlap with Sjögren’s syndrome in 21 cases (72%) (p < 0.001) with a Pathological MSGB more frequent. Higher prevalence of Objective Sicca syndrome in 58% of cases (p = 0.044) along with the Presence of anti-SSA antibodies in 87.5% of cases (p = 0.014), and a Longer disease duration (p = 0.044). No association was found between a JJ score ≥ 2 and visceral disease involvement.- On the other side, patient with a Fibrosis score ≥ 2 compared to those with a fibrosis score < 2, presented a longer disease duration (p = 0.014). There was no association between either score and the disease-specific antibodies or visceral involvement, such as cutaneous, pulmonary, articular, or renal involvement.

Conclusion: Ultrasound abnormalities of major salivary glands are common in patients with SSc. A global JJ score ≥ 2 should raise suspicion of an overlapped Sjögren’s syndrome. However, while fibrotic lesions are common, they do not appear to be related to the severity of the SSc phenotype.

Supporting image 1Table: Features of our Systemic sclerosis patients evaluated


Disclosures: R. D'Alessandro: None; F. Zimmermann: None; s. jousse: None; A. BLEUZEN: None; G. Coiffier: AbbVie/Abbott, 6, Eli Lilly, 6, Janssen, 6, UCB, 6; J. Avouac: AbbVie, 2, 6, Alfasigma S.p.A., 6, BMS, 5, 6, Celltrion, 6, Eli Lilly & Co., 6, Fresenius Kabi, 5, Galapagos, 2, 6, Novartis, 5, 6, Pfizer, 5, 6; A. Lescoat: None; Y. Allanore: None.

To cite this abstract in AMA style:

D'Alessandro R, Zimmermann F, jousse s, BLEUZEN A, Coiffier G, Avouac J, Lescoat A, Allanore Y. Major salivary glands Ultrasound features in a group of patients with systemic sclerosis: a multicentric study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/major-salivary-glands-ultrasound-features-in-a-group-of-patients-with-systemic-sclerosis-a-multicentric-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/major-salivary-glands-ultrasound-features-in-a-group-of-patients-with-systemic-sclerosis-a-multicentric-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology